Regenerex Pharma enters licensing deal with Holista for ovine collagen wound care

REGENEREX PHARMA, INC.

Exclusive rights to use Holista's ovine collagen in wound care and distribution in USA.
Ovine nano-collagen integrated into Regenerex's QBx™ technology to accelerate deep tissue regeneration.
Collagen sourced from ethically raised, disease-free Australian sheep; avoids mad cow disease concerns.
CEO Greg Pilant says ovine collagen is safer and more culturally acceptable than bovine/porcine sources.
Agreement targets advanced wound care solutions for U.S. and international markets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.